Follow-Up Recommendations for Colon Cancer

W. Donald Buie; Jo-Anne P. Attard

doi:10.1055/s-2005-916284

Clinics in Colon and Rectal Surgery, Table of Contents

Clin Colon Rectal Surg 2005; 18(3): 232-243
DOI: 10.1055/s-2005-916284

Follow-Up Recommendations for Colon Cancer

W. Donald Buie¹ ^, ² , Jo-Anne P. Attard¹

¹Department of Surgery, University of Calgary, Calgary, Alberta, Canada
²Department of Oncology, University of Calgary, Calgary, Alberta, Canada

Abstract

ABSTRACT

Recent evidence suggests that intensive follow-up after curative resection of colorectal cancer is associated with a small but significant improvement in survival. Regimens that employ cross-sectional imaging and carcinoembryonic antigen determination appear to have the greatest benefit. A risk-adapted approach to follow-up, intensively following patients at highest risk of recurrence, increases efficacy and cost-effectiveness. Ongoing improvements in risk stratification, disease detection, and treatment will increase the benefits of postoperative surveillance. Large randomized controlled trials are needed to determine the optimal surveillance regimen and must include an analysis of survival, quality of life, and cost-effectiveness to assess efficacy properly.

KEYWORDS

Colorectal neoplasm - neoplasm recurrence/detection - neoplasm metastasis/diagnosis - surveillance - follow-up - survival

Full Text

References

REFERENCES

1 Bohm B, Schwenk W, Hucke H P et al.. Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma?. Dis Colon Rectum. 1993; 36 280-286
2 Falterman K W, Hill C B, Markey J C et al.. Cancer of the colon, rectum, and anus: a review of 2313 cases. Cancer. 1974; 34:suppl 951-9
3 Moertel C G, Fleming T R, Macdonald J S et al.. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990; 322 352-358
4 Olson R M, Perencevich N P, Malcolm A W et al.. Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum. Cancer. 1980; 45 2969-2974
5 Pestana C, Reitemeier R J, Moertel C G et al.. The natural history of carcinoma of the colon and rectum. Am J Surg. 1964; 108 826-829
6 Safi F, Beyer H G. The value of follow-up after curative surgery of colorectal carcinoma. Cancer Detect Prev. 1993; 17 417-424
7 Goldberg R M, Fleming T R, Tangen C M et al.. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med. 1998; 129 27-35
8 Scholefield J H, Steele R J. Guidelines for follow up after resection of colorectal cancer. Gut. 2002; 51(suppl 5) V3-V5
9 Ohlsson B, Breland U, Ekberg H et al.. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum. 1995; 38 619-626
10 Deveney K E, Way L W. Follow-up of patients with colorectal cancer. Am J Surg. 1984; 148 717-722
11 Sugarbaker P H, Gianola F J, Dwyer A et al.. A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. Surgery. 1987; 102 79-87
12 Meyerhardt J A, Mayer R J. Follow-up strategies after curative resection of colorectal cancer. Semin Oncol. 2003; 30 349-360
13 Hughes K S, Simon R, Songhorabodi S et al.. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery. 1986; 100 278-284
14 Ballantyne G H, Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer. 1993; 71 4252-4266
15 McAfee M K, Allen M S, Trastek V F et al.. Colorectal lung metastases: results of surgical excision. Ann Thorac Surg. 1992; 53 780-785
16 Fong Y, Cohen A M, Fortner J G et al.. Liver resection for colorectal metastases. J Clin Oncol. 1997; 15 938-946
17 Steele Jr G. Standard postoperative monitoring of patients after primary resection of colon and rectum cancer. Cancer. 1993; 71 4225-4235
18 Pietra N, Sarli L, Costi R et al.. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum. 1998; 41 1127-1133
19 Secco G B, Fardelli R, Gianquinto D et al.. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol. 2002; 28 418-423
20 Renehan A G, Egger M, Saunders M P et al.. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ. 2002; 324 813
21 Jeffery G M, Hickey B E, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2002; , 1. art. no. CD002200 DOI 10.1002/14651858-1-26
22 Tornqvist A, Ekelund G, Leandoer L. Early diagnosis of metachronous colorectal carcinoma. Aust N Z J Surg. 1981; 51 442-445
23 Heald R J, Lockhart-Mummery H E. The lesion of the second cancer of the large bowel. Br J Surg. 1972; 59 16-19
24 McArdle C. ABC of colorectal cancer: effectiveness of follow up. BMJ. 2000; 321 1332-1335
25 Anthony T, Simmang C, Hyman N et al.. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum. 2004; 47 807-817
26 Stiggelbout A M, de Haes J C, Vree R et al.. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer. 1997; 75 914-920
27 Kiebert G M, Welvaart K, Kievit J. Psychological effects of routine follow up on cancer patients after surgery. Eur J Surg. 1993; 159 601-607
28 Kjeldsen B J, Thorsen H, Whalley D et al.. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand J Gastroenterol. 1999; 34 509-515
29 Hennekens C, Buring J. Epidemiology in Medicine. Philadelphia; Lippincott Williams & Wilkins 1987: 327-347
30 Phillips R K, Hittinger R, Blesovsky L et al.. Large bowel cancer: surgical pathology and its relationship to survival. Br J Surg. 1984; 71 604-610
31 Finlay I G, McArdle C S. Occult hepatic metastases in colorectal carcinoma. Br J Surg. 1986; 73 732-735
32 Figueredo A, Rumble R B, Maroun J et al.. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003; 3 26
33 Gordis L. Epidemiology. 2nd ed. Philadelphia; WB Saunders 2000: 60-70
34 Wein A, Riedel C, Bruckl W et al.. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer. Oncology. 2003; 64 131-138
35 Pozzo C, Basso M, Cassano A et al.. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol. 2004; 15 933-939
36 Johnson F E, Virgo K S, Fossati R. Follow-up for patients with colorectal cancer after curative-intent primary treatment. J Clin Oncol. 2004; 22 1363-1365
37 Vernava III A M, Longo W E, Virgo K S et al.. Current follow-up strategies after resection of colon cancer. Results of a survey of members of the American Society of Colon and Rectal Surgeons. Dis Colon Rectum. 1994; 37 573-583
38 Kjeldsen B J, Kronborg O, Fenger C et al.. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg. 1997; 84 666-669
39 Mäkelä J T, Laitinen S O, Kairaluoma M I. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg. 1995; 130 1062-1067
40 Schoemaker D, Black R, Giles L et al.. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology. 1998; 114 7-14
41 Staib L, Link K H, Beger H G. Follow-up in colorectal cancer: cost-effectiveness analysis of established and novel concepts. Langenbecks Arch Surg. 2000; 385 412-420
42 Desch C E, Benson III A B, Smith T J et al.. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol. 1999; 17 1312
43 Fleischer D E, Goldberg S B, Browning T H et al.. Detection and surveillance of colorectal cancer. JAMA. 1989; 261 580-585
44 Engstrom P F, Benson III A B, Cohen A et al.. NCCN Colorectal Cancer Practice Guidelines. The National Comprehensive Cancer Network. Oncology (Williston Park). 1996; 10(11 suppl) 140-175
45 Practice NCCN .Guidelines in Oncology-v2. 2005 Colon Cancer http://www.nccn.org/professionals/physicians_gls/PDF/colon.pdf
46 Fantini G A, DeCosse J J. Surveillance strategies after resection of carcinoma of the colon and rectum. Surg Gynecol Obstet. 1990; 171 267-273
47 Galandiuk S, Wieand H S, Moertel C G et al.. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet. 1992; 174 27-32
48 Mäkelä J, Haukipuro K, Laitinen S et al.. Surgical treatment of recurrent colorectal cancer. Five-year follow-up. Arch Surg. 1989; 124 1029-1032
49 Ovaska J, Jarvinen H, Kujari H et al.. Follow-up of patients operated on for colorectal carcinoma. Am J Surg. 1990; 159 593-596
50 Tornqvist A, Ekelund G, Leandoer L. The value of intensive follow-up after curative resection for colorectal carcinoma. Br J Surg. 1982; 69 725-728
51 Richard C S, McLeod R S. Follow-up of patients after resection for colorectal cancer: a position paper of the Canadian Society of Surgical Oncology and the Canadian Society of Colon and Rectal Surgeons. Can J Surg. 1997; 40 90-100
52 Graffner H, Hultberg B, Johansson B et al.. Detection of recurrent cancer of the colon and rectum. J Surg Oncol. 1985; 28 156-159
53 Graham R A, Wang S, Catalano P J et al.. Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy. Ann Surg. 1998; 228 59-63
54 McCall J L, Black R B, Rich C A et al.. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum. 1994; 37 875-881
55 Moertel C G, Fleming T R, Macdonald J S et al.. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA. 1993; 270 943-947
56 Fletcher R H. Carcinoembryonic antigen. Ann Intern Med. 1986; 104 66-73
57 Goslin R, Steele Jr G, Macintyre J et al.. The use of preoperative plasma CEA levels for the stratification of patients after curative resection of colorectal cancers. Ann Surg. 1980; 192 747-751
58 Fucini C, Tommasi S M, Rosi S et al.. Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery. Dis Colon Rectum. 1987; 30 273-277
59 Martin Jr E W, Cooperman M, Carey L C et al.. Sixty second-look procedures indicated primarily by rise in serial carcinoembryonic antigen. J Surg Res. 1980; 28 389-394
60 Goya T, Miyazawa N, Kondo H et al.. Surgical resection of pulmonary metastases from colorectal cancer. 10-year follow-up. Cancer. 1989; 64 1418-1421
61 McCormack P M, Attiyeh F F. Resected pulmonary metastases from colorectal cancer. Dis Colon Rectum. 1979; 22 553-556
62 Smith T J, Bear H D. Standard follow-up of colorectal cancer patients: finally, we can make practice guidelines based on evidence. Gastroenterology. 1998; 114 211-213
63 Chau I, Allen M J, Cunningham D et al.. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol. 2004; 22 1420-1429
64 Adam R, Avisar E, Ariche A et al.. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol. 2001; 8 347-353
65 Giacchetti S, Itzhaki M, Gruia G et al.. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol. 1999; 10 663-669
66 Winawer S, Fletcher R, Rex D et al.. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology. 2003; 124 544-560
67 Anthony T, Fleming J B, Bieligk S C et al.. Postoperative colorectal cancer surveillance. J Am Coll Surg. 2000; 190 737-749
68 Cali R L, Pitsch R M, Thorson A G et al.. Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum. 1993; 36 388-393
69 Green R J, Metlay J P, Propert K et al.. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Intern Med. 2002; 136 261-269
70 Winawer S J, Zauber A G, Ho M N et al.. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993; 329 1977-1981
71 Norum J, Olsen J A. A cost-effectiveness approach to the Norwegian follow-up programme in colorectal cancer. Ann Oncol. 1997; 8 1081-1087
72 Liberati A, Torri V, Apolone G. Assessing the effectiveness of follow-up care for colorectal cancer: a great conceptual and methodological challenge for clinical oncology. Ann Oncol. 1997; 8 1059-1062
73 Borie F, Combescure C, Daures J P et al.. Cost-effectiveness of two follow-up strategies for curative resection of colorectal cancer: comparative study using a Markov model. World J Surg. 2004; 28 563-569
74 Virgo K S, Vernava A M, Longo W E et al.. Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA. 1995; 273 1837-1841
75 Bruinvels D J, Stiggelbout A M, Kievit J et al.. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg. 1994; 219 174-182
76 Renehan A G, O'Dwyer S T, Whynes D K. Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer. BMJ. 2004; 328 81
77 Kraemer M, Wiratkapun S, Seow-Choen F et al.. Stratifying risk factors for follow-up: a comparison of recurrent and nonrecurrent colorectal cancer. Dis Colon Rectum. 2001; 44 815-821
78 ESMO .Minimum Clinical Recommendations. 2002 http://www.esmo.org/reference/reference_guidelines.htm

W. Donald BuieM.D.

Foothills Hospital/SSB Rm. AC144D

1403 29th St., NW, Calgary, AB T2N 2T9 Canada

Email: wdbuie@ucalgary.ca